| Literature DB >> 25347864 |
Cory W Baumann1, Russell G Rogers1, Nidhi Gahlot1, Christopher P Ingalls1.
Abstract
Strength deficits associated with eccentric contraction-induced muscle injury stem, in part, from impaired voltage-gated sarcoplasmic reticulum (SR) Ca(2+) release. FKBP12 is a 12-kD immunophilin known to bind to the SR Ca(2+) release channel (ryanodine receptor, RyR1) and plays an important role in excitation-contraction coupling. To assess the effects of eccentric contractions on FKBP12 content, we measured anterior crural muscle (tibialis anterior [TA], extensor digitorum longus [EDL], extensor hallucis longus muscles) strength and FKBP12 content in pellet and supernatant fractions after centrifugation via immunoblotting from mice before and after a single bout of either 150 eccentric or concentric contractions. There were no changes in peak isometric torque or FKBP12 content in TA muscles after concentric contractions. However, FKBP12 content was reduced in the pelleted fraction immediately after eccentric contractions, and increased in the soluble protein fraction 3 day after injury induction. FKBP12 content was correlated (P = 0.025; R(2) = 0.38) to strength deficits immediately after injury induction. In summary, eccentric contraction-induced muscle injury is associated with significant alterations in FKBP12 content after injury, and is correlated with changes in peak isometric torque.Entities:
Keywords: Damage; force; mouse; recovery; skeletal muscle
Year: 2014 PMID: 25347864 PMCID: PMC4187567 DOI: 10.14814/phy2.12081
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Figure 1.Experimental time line for the eccentric (A) and concentric (B) contraction protocols. T‐f, isometric torque as a function of frequency; F‐f, isometric force as a function of frequency. WB, western blot.
Figure 2.Representative torque output as a function of time during a single contraction during the eccentric and concentric contraction protocols (A; Note: the rapid spikes at the end of the movements correspond to inertia artifacts of the lever arm), peak in vivo torque produced during 150 eccentrics or concentric contractions (B), isometric torque as a function of stimulation frequency after either 150 concentric contractions (C) or eccentric contractions (D). Isometric torque measurements were made before (Pre), immediately (0 d) and 3 days (3 d) after the concentric contraction bout (C), and immediately, 3 days and 14 days (14 d) after the eccentric contraction bout (D). Isometric torque data were modeled with equation 1, listed in Material and Methods. *Torque immediately after exercise is significantly different from preexercise; #torque 3 days after exercise is significantly different from preexercise; †torque 14 days after exercise is significantly different from preexercise; **significantly different from concentric. Values are means ± SE.
Anterior crural muscle in vivo isometric torque parameters
| Concentric | Eccentric | ||||||
|---|---|---|---|---|---|---|---|
| Pre | 0 day | 3 day | Pre | 0 day | 3 day | 14 day | |
| Sample size | 16 | 16 | 8 | 38 | 38 | 13 | 10 |
| Body weight (g) | 24.4 ± 0.6 | 24.4 ± 0.6 | 23.9 ± 0.5 | 24.3 ± 0.4 | 24.3 ± 0.4 | 23.7 ± 0.5 | 23.9 ± 0.7 |
| Minmeas (N mm kg−1) | 23.7 ± 1.0 | 14.4 ± 0.7 | 23.3 ± 1.0 | 22.6 ± 0.6 | 2.3 ± 0.2 | 4.4 ± 0.8 | 22.0 ± 1.0 |
| Maxmeas (N mm kg−1) | 99.9 ± 3.2 | 102.6 ± 3.4 | 93.9 ± 2.9 | 98.8 ± 1.5 | 50.2 ± 1.4 | 43.6 ± 3.9 | 84.9 ± 2.5 |
| Minestim (N mm kg−1) | 21.8 ± 0.9 | 12.2 ± 0.5 | 21.7 ± 1.0 | 20.6 ± 0.6 | 1.9 ± 0.2 | 4.2 ± 0.8 | 19.7 ± 0.8 |
| Maxestim (N mm kg−1) | 97.5 ± 3.3 | 101.0 ± 3.6 | 91.5 ± 3.0 | 96.5 ± 1.4 | 50.8 ± 1.4 | 44.3 ± 3.8 | 82.7 ± 2.4 |
| EC50 (Hz) | 85.0 ± 1.7 | 97.1 ± 1.5 | 76.0 ± 1.7 | 88.2 ± 0.9 | 140.1 ± 1.5 | 94.5 ± 2.4 | 82.0 ± 2.3 |
| 6.53 ± 0.2 | 5.83 ± 0.2 | 6.65 ± 0.2 | 6.62 ± 0.2 | 6.38 ± 0.2 | 4.54 ± 0.2 | 5.82 ± 0.3 | |
Values are means ± SE. The minimum (Min) and maximum (Max) torques measured and estimated represent twitch and peak tetanic torques, respectively. EC50 is the stimulation frequency at which half of the rise in amplitude of torque occurred. The n coefficient describes the slope of the steep portion of the torque–frequency curves depicted in Figure 2. Pre, 0 day, 3 day, and 14 day: time course of contractions, that is, before and immediately, 3 or 14 days after, respectively.
Significantly different from Concentric Pre and 3 day.
Significantly different from Eccentric Pre and 14 days.
Significantly different from Eccentric Pre, 0 and 3 days.
Significantly different from all other Eccentric groups.
Significantly different from Eccentric Pre and 0 day groups. P ≤ 0.05.
Figure 3.Ex vivo extensor digitorum longus (EDL) muscle isometric force as a function of stimulation frequency after the concentric (A) and eccentric (B) contraction bouts. Isometric force data were modeled with equation 1, listed in Material and Methods. Percent changes in resting tension (C) and peak submaximal isometric force (D) during 3 min of 2 mmol L−1 caffeine exposure. Isometric force measurements were made in control muscles and in muscle immediately (0 d) and 3 days (3 d) after the concentric contraction bout, and immediately, 3 days and 14 days (14 d) after the eccentric contraction bout. Concentric contraction groups (0 and 3 d) were combined in C and D. *Force immediately after exercise is significantly different from control; #force 3 days after exercise is significantly different from control; †force 14 days after exercise is significantly different from control; ‡significantly different from all other values; **significantly different from control. Values are means ± SE.
Extensor digitorum longus (EDL) muscle ex vivo isometric force parameters
| Control | Concentric | Eccentric | ||||
|---|---|---|---|---|---|---|
| 0 day | 3 day | 0 day | 3 day | 14 day | ||
| Sample size | 10 | 8 | 8 | 11 | 8 | 8 |
| EDL (mg) | 9.6 ± 0.3 | 11.9 ± 0.2 | 11.1 ± 0.3 | 11.8 ± 0.2 | 12.0 ± 0.3 | 10.7 ± 0.2 |
| 1.40 ± 0.01 | 1.44 ± 0.02 | 1.41 ± 0.01 | 1.38 ± 0.02 | 1.41 ± 0.03 | 1.42 ± 0.02 | |
| Minmeas (N cm−2) | 3.86 ± 0.2 | 2.89 ± 0.2 | 3.55 ± 0.2 | 0.87 ± 0.1 | 1.88 ± 0.1 | 3.21 ± 0.2 |
| Maxmeas (N cm−2) | 24.9 ± 0.7 | 22.7 ± 0.8 | 21.3 ± 1.1 | 7.0 ± 0.6 | 9.7 ± 0.5 | 20.1 ± 0.9 |
| Minestim (N cm−2) | 3.85 ± 0.2 | 2.8 ± 0.1 | 3.6 ± 0.2 | 0.9 ± 0.1 | 1.4 ± 0.1 | 3.2 ± 0.2 |
| Maxestim (N cm−2) | 24.8 ± 0.6 | 23.1 ± 0.7 | 21.5 ± 1.1 | 7.5 ± 0.7 | 10.2 ± 0.5 | 20.3 ± 0.9 |
| EC50 (Hz) | 91.4 ± 1.7 | 85.3 ± 3.6 | 83.6 ± 3.5 | 116.1 ± 5.3 | 109.0 ± 4.8 | 86.1 ± 1.1 |
| 4.2 ± 0.1 | 2.9 ± 0.04 | 3.5 ± 0.1 | 3.0 ± 0.1 | 3.0 ± 0.1 | 3.5 ± 0.1 | |
| 50 mmol L−1 Caffeine (N cm−2) | 6.5 ± 0.25 | 6.1 ± 0.14 | 6.3 ± 0.24 | 4.7 ± 0.15 | 4.8 ± 0.12 | 6.5 ± 0.2 |
| 50 mmol L−1 Caf/ | 27.3 ± 0.73 | 26.4 ± 0.51 | 30.0 ± 1.20 | 70.0 ± 4.35 | 50.6 ± 1.93 | 32.6 ± 1.03 |
Values are means ± SE. Lo is optimal muscle length coinciding with peak twitch force; Minimum and maximum forces measured (meas) and estimated (estim) represent twitch and peak tetanic forces, respectively. EC50 is the stimulation frequency at which half of the rise in amplitude of force occurred. The n coefficient describes the slope of the steep portion of the force‐frequency curves depicted in Figure 3. EDL, extensor digitorum longus muscle. Pre, 0 day, 3 day, and 14 day: time course of contractions, that is, before and immediately, 3 or 14 days after, respectively.
Significantly different from Control.
Significantly different from Control, Concentric 0 and 3 days, and Eccentric 14 days.
Significantly different from Control, Concentric 0 and 3 days, Eccentric 3 and 14 days.
Significantly different from Control, Concentric 0 and 3 days, Eccentric 0 and 14 days. P ≤ 0.05.
Tibialis anterior (TA) muscle wet weight and protein parameters
| Control | Concentric | Eccentric | ||||
|---|---|---|---|---|---|---|
| 0 day | 3 day | 0 day | 3 day | 14 day | ||
| Sample size | 10–22 | 4–8 | 4–8 | 8–15 | 8–11 | 8–10 |
| TA muscle weight (mg) | 40.9 ± 0.9 | 40.9 ± 0.8 | 43.4 ± 0.6 | 44.2 ± 0.6 | 45.4 ± 0.5 | 40.9 ± 1.3 |
| TA/body weight (mg g−1) | 1.8 ± 0.03 | 1.7 ± 0.06 | 1.8 ± 0.04 | 1.8 ± 0.04 | 1.9 ± 0.04 | 1.7 ± 0.04 |
| TA total protein (mg per muscle) | 14.6 ± 0.6 | 13.6 ± 0.9 | 14.9 ± 1.0 | 15.2 ± 0.5 | 15.2 ± 0.7 | 13.4 ± 0.6 |
| TA total protein (% wet wt.) | 35.3 ± 1.3 | 32.9 ± 2.2 | 34.3 ± 2.4 | 35.2 ± 1.1 | 33.3 ± 1.4 | 32.0 ± 1.2 |
| TA pellet protein (mg per muscle) | 6.0 ± 0.3 | 5.6 ± 0.7 | 6.6 ± 0.8 | 5.8 ± 0.3 | 4.8 ± 0.5 | 5.4 ± 0.7 |
| TA pellet protein (% wet wt.) | 15.2 ± 0.8 | 13.9 ± 2.2 | 15.1 ± 1.9 | 13.3 ± 0.9 | 10.5 ± 1.2 | 12.9 ± 1.1 |
| TA soluble protein (mg per muscle) | 5.0 ± 0.1 | 5.3 ± 0.1 | 5.5 ± 0.1 | 5.3 ± 0.2 | 5.3 ± 0.2 | 4.4 ± 0.3 |
| TA soluble protein (% wet wt.) | 12.1 ± 0.2 | 12.8 ± 0.3 | 12.6 ± 0.4 | 12.1 ± 0.4 | 11.7 ± 0.5 | 10.6 ± 0.6 |
Values are means ± SE. Tibialis anterior muscle protein content was determined in whole muscle homogenate (total) and supernatant (soluble) and pellet fractions after centrifugation. Pre, 0 day, 3 day, and 14 day: time course of contractions, that is, before and immediately, 3 or 14 days after, respectively. Control includes nonexercised contralateral TA muscles.
Significantly different from Control.
Significantly different from Concentric 0 day and Eccentric 14 day.
Significantly different from all other groups except Control.
Significantly different from all other groups except Eccentric 3 day (P ≤ 0.05).
Figure 4.FKBP12 protein content in the supernatant (A and C) and pellet (B and D) of TA muscle after in vivo concentric (“C”) and eccentric (“E”) contractions. FKBP12 was normalized to GAPDH in the supernatant (A and C) and to the protein band corresponding to actin in the pellet (B and D). FKBP12 was determined via Western blot in unexercised control muscle, and in muscles immediately (0 d), 3 days (3 d) and 14 days (14 d) after either concentric or eccentric contractions. FKBP12 content was not different between the two concentric groups, and the data were combined. *Significantly different from Control. Values are means ± SE. TA, Tibialis anterior.